ASTC

Launch of TRACER 1000 NTD: Astrotech Corporation has introduced the enhanced TRACER 1000™ Narcotics Trace Detector, which utilizes advanced mass spectrometry to effectively identify a wide range of synthetic opiates and novel psychoactive substances, providing rapid and precise detection for law enforcement and public safety agencies.

Addressing Synthetic Drug Crisis: The TRACER 1000 NTD aims to combat the growing epidemic of synthetic drugs by offering high sensitivity and quick results, thereby assisting authorities in preventing dangerous substances from reaching communities and enhancing overall safety.

Astrotech's New Product Launch: Astrotech has launched the TRACER 1000 Narcotics Trace Detector, designed to effectively screen for synthetic opiates and novel psychoactive substances, enhancing efforts to combat the global drug crisis.

Company Developments: The company has made several announcements including a new subsidiary EN-SCAN, financial results for Q2, and changes in executive leadership with the resignation of CFO Hinojosa.

Financial Performance: Astrotech Corporation reported a revenue of $295 thousand for Q2 of fiscal year 2025, mainly from its work with the U.S. Department of Homeland Security on explosives trace detection technology, while also facing a net loss of $4 million.

Product Development and Market Expansion: The company is focusing on marketing its TRACER 1000™ explosive trace detectors and has introduced a new narcotics trace detector, aiming to enter large markets with proven mass spectrometry technology.

Astrotech's Purchase Order: Astrotech Corporation's subsidiary, 1st Detect, has received a $429K purchase order for its TRACER 1000 explosive trace detectors from Intuitive Research and Technology Corporation, marking a significant milestone as the first TSA-approved sale of this technology.

Mass Spectrometry Technology: The TRACER 1000 utilizes Astrotech's Mass Spectrometer Technology™, which enables near-zero false alarms in chemical detection, making it suitable for the U.S. cargo market while addressing challenges associated with traditional mass spectrometry methods.

Astrotech Corporation Awarded DHS Contract: Astrotech Corporation and its subsidiary, 1st Detect, have received a research and development contract from the U.S. Department of Homeland Security to develop the TRACER 1000 explosives trace detection system, with a total potential value of $1,290,650 over 30 months.

Project Phases and CEO Statement: The project consists of two phases, each lasting 15 months, with the first phase valued at $581,639. CEO Tom Pickens expressed optimism about the collaboration with DHS to enhance airport security through advanced explosive detection technology.

Financial Performance: Astrotech Corporation reported a revenue increase to $1.7 million for the fiscal year ending June 30, 2024, with a gross margin rise to 45%, attributed to growth in recurring revenue from its explosives trace detectors and narcotics trace detectors.

Product Developments and Approvals: The TRACER 1000 received TSA approval for air cargo security, allowing field trials and potential sales to U.S. air cargo companies, while the company also launched a new subsidiary, Pro-Control, focusing on industrial process control applications using mass spectrometry technology.

ProFrac Holding Corp Insider Trade: Dan H. Wilks, a 10% owner, acquired over 1 million shares, while the Executive Chairman also bought 10,000 shares.

ProFrac Holding News: CFO Lance Turner will resign effective June 17.

Immunome, Inc. Insider Trade: President and CEO Clay B Siegall purchased 100,000 shares at an average price of $13.88.

Immunome Quarterly Results: The company posted downbeat quarterly results on May 14.

Globe Life Inc. Insider Trade: Co-Chairman and CEO Frank M Svoboda acquired 2,500 shares at an average price of $86.31.

Globe Life Analyst Rating: Raymond James analyst reiterated Globe Life with a Strong Buy on May 21.

Astrotech Corporation Insider Trade: Director Thomas Wiley Wilkinson bought 1,109 shares at an average price of $9.50.

Astrotech Quarterly Results: Astrotech posted a wider loss for the third quarter on May 13.